Quantitative proteomics unveiled: Regulation of DNA double strand break repair by EGFR involves PARP1-Reference-Cited by-同舟云学术

Quantitative proteomics unveiled: Regulation of DNA double strand break repair by EGFR involves PARP1

Published:2015-09 Issue:3 Volume:116 Page:423-430
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Myllynen Laura,Kwiatkowski Marcel,Gleißner Lisa,Riepen Britta,Hoffer Konstantin,Wurlitzer Marcus,Petersen Cordula,Dikomey Ekkehard,Rothkamm Kai,Schlüter Hartmut,Kriegs Malte

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference34 articles.

1. Radiosensitization of NSCLC cells by EGFR inhibition is the result of an enhanced p53-dependent G1 arrest;Kriegs;Radiother Oncol,2015

2. Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa);Huang;Cancer Res,2002

3. EGFR-targeted anti-cancer drugs in radiotherapy: preclinical evaluation of mechanisms;Baumann;Radiother Oncol,2007

4. Receptor signaling as a regulatory mechanism of DNA repair;Meyn;Radiother Oncol,2009

5. The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining;Kriegs;DNA Repair,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into DNA damage repair defects in HPV-positive head and neck squamous cell carcinoma: from the molecular basis to therapeutic opportunities;Genome Instability & Disease;2023-10-11

2. Analyzing tyrosine kinase activity in head and neck cancer by functional kinomics: Identification of hyperactivated Src family kinases as prognostic markers and potential targets;International Journal of Cancer;2021-05-07

3. Head and neck cancer: the role of anti-EGFR agents in the era of immunotherapy;Therapeutic Advances in Medical Oncology;2021-01

4. Combined EGFR1 and PARP1 Inhibition Enhances the Effect of Radiation in Head and Neck Squamous Cell Carcinoma Models;Radiation Research;2020-09-16

5. Synergistic Anti-Tumour Effect of Syk Inhibitor and Olaparib in Squamous Cell Carcinoma: Roles of Syk in EGFR Signalling and PARP1 Activation;Cancers;2020-02-19